Thrombosis
News
BMS recalls a lot of Eliquis 5 mg tablets
The Eliquis 5 mg lot, distributed nationwide, contains the wrong dosage.
News
Researchers design new, safer antiplatelet drug based on snake venom
Researchers say they have designed an antiplatelet drug based on snake venom protein that stimulates platelets to form blood clots by latching...
Conference Coverage
Low-dose aspirin bests dual-antiplatelet therapy in TAVR
PARIS – ARTE trial is hailed as practice changing.
News
Team finds inappropriate dosing of blood thinners
Patients with atrial fibrillation (AF) and renal impairment require dose reductions of non-vitamin K antagonist oral anticoagulants (NOACs). But...
News
Recombinant coagulation factor IX approved for hemophilia B
Nonacog beta pegol (N9-GP, Rebinyn®), a recombinant, GlycoPEGylated coagulation factor IX, has been approved by the US Food and Drug...
News
Preventing thrombosis without increasing bleeding risk
It may be possible to disrupt thrombosis without increasing the risk of bleeding, according to preclinical research published in Nature...
News
EMA recommends orphan designation for hemophilia B product
The European Medicines Agency’s (EMA’s) Committee for Orphan Medicinal Products has issued a positive opinion recommending orphan designation for...
News
AstraZeneca recalls lot of Brilinta in US
AstraZeneca has announced a voluntary recall of 1 lot of professional (physician) sample bottles containing 8 tablets of Brilinta® (ticagrelor)....
News
Finding could lead to ‘Holy Grail’ of antithrombotic therapy
The protein CIB1 may be a superior target for antithrombotic therapy, according to researchers. The team found that CIB1 plays a role in thrombus...
From the Journals
Infections up the risk for pregnancy-associated stroke in preeclampsia
A study in a diverse population of pregnant women with preeclampsia has identified several risk factors for pregnancy-associated stroke.
News
PK-guided prophylaxis reduces dosing, still prevents bleeds
Personalized prophylaxis with a recombinant factor VIII product allowed for reduced dosing while still providing protection from bleeds in a small...